Two Time Scales of Response Loss
A drug effect can diminish quickly during one dosing episode or appear weaker after repeated doses over a longer period. Both patterns may be called tolerance in broad usage, but distinguishing their time scales is useful: a rapid within-episode change is described as acute tachyphylaxis, whereas a gradual reduction in response across repeated or prolonged exposure is described as chronic tolerance. These are operational descriptions of observed patterns, not explanations of why the response changed.
The timing of measurements matters. To assess a change within an episode, follow response serially while the drug is being administered or remains present. To assess a change across repeated doses, compare corresponding observations across doses or treatment days. In either case, concentration and response should be considered together. A response that is smaller when concentration is also lower does not, by itself, show that sensitivity to the drug has changed.
For clarity, let \(C(t)\) denote measured drug concentration at time \(t\), and let \(R(t)\) denote the drug-related response expressed as a baseline-adjusted effect magnitude, with larger positive values meaning a stronger effect in the direction of interest. For an inhibitory endpoint, the direction can be defined so that a larger \(R(t)\) still means a stronger drug effect. This convention prevents a decrease in the raw biomarker from being confused with a decrease in effect.
Reading a Within-Episode Record
A within-episode record supports a description of acute tachyphylaxis when the response falls rapidly while concentration is maintained or is comparable at the observations being contrasted. A response can also fall while concentration changes, but that pattern is less informative: concentration-related change, delayed response, or other time-varying influences may account for it. The strongest simple comparison is between observations from the same episode with comparable concentrations and a clear difference in response.
The proportional attenuation between an earlier and a later observation can be summarized as:
This calculation is meaningful when \(R_{\mathrm{early}}>0\), the response scale is consistent, and both values refer to comparable conditions. It describes the observed change; it does not test a mechanism or establish that concentration has no influence.
Worked Example: Rapid Attenuation at a Maintained Concentration
In a hypothetical single-dose experiment, concentration and baseline-adjusted response are recorded during one dosing episode. Assume the assay and response scale are stable throughout, and no concurrent intervention occurs.
| Time after dose (h) | Concentration (mg/L) | Response (effect units) |
|---|---|---|
| 1 | 4 | 20 |
| 2 | 8 | 36 |
| 3 | 12 | 40 |
| 4 | 12 | 22 |
The most direct comparison is at 3 and 4 hours: concentration is 12 mg/L at both observations, but response falls from 40 to 22 effect units. The estimated attenuation is:
Thus, the record shows a 45% lower response at the later observation despite the same measured concentration. Because this occurs within one episode, the pattern is consistent with acute tachyphylaxis. It does not establish the process responsible: for example, a delayed response process or a changing baseline could also contribute. The conclusion is about the observed pattern, conditional on the measurement and design assumptions.
A loop in a concentration-effect plot—different responses at the same concentration on the rising and falling parts of the concentration profile—is not sufficient evidence of tachyphylaxis. Delays between concentration and response can also produce such a loop. Serial timing, the direction of change, baseline behavior, and repeated observations help determine whether rapid response loss is a reasonable description.
Comparing Responses Across Repeated Doses
Chronic tolerance is assessed across a longer time scale. A useful comparison pairs response observations made at similar points in the dosing interval and at comparable concentrations on different days or after different numbers of doses. If concentration and response timing are not comparable, an apparent reduction in response may instead reflect a different exposure or a different point on a delayed response trajectory. A single lower response after repeated treatment is therefore not enough to classify the pattern confidently.
The comparison should also use a stable response definition. If the untreated baseline changes over time, compare baseline-adjusted responses rather than raw measurements. If dose timing, co-medications, endpoint measurement, or patient condition changes, record those changes and consider whether they could explain the apparent response difference. These safeguards do not identify a mechanism; they make the descriptive comparison more defensible.
Worked Example: Lower Response Across Treatment Days
In a hypothetical repeated-dose record, observations are taken at the same postdose time on treatment days 1 and 8. The measured concentrations are both 10 mg/L. Baseline-adjusted responses are 30 and 18 effect units, respectively. Assume the response assay, dose timing, and relevant measurement conditions are comparable, and there is no evidence of a changing baseline.
The response attenuation from day 1 to day 8 is:
At the matched concentration and postdose time, the later response is 12 effect units lower, or 40% below the day 1 response. This is a pattern consistent with chronic tolerance because the reduction is observed across repeated treatment days, rather than only within one episode. The record alone does not determine why the response is lower. Additional observations would be needed to evaluate whether the pattern is reproducible and whether other time-varying influences are present.
It can be helpful to inspect both scales in the same study: serial observations within selected dosing episodes, and comparable observations across treatment days. The first addresses rapid within-episode attenuation; the second addresses gradual across-dose change. If both patterns occur, they should be described separately rather than collapsed into a single label.
When Concentrations Do Not Match
A response difference across days is difficult to interpret when the concentrations differ. The following hypothetical record illustrates the problem. Suppose the endpoint is in a range where a proportional response-concentration relationship is a reasonable local approximation, and the baseline-adjusted responses and measured concentrations are as shown.
Worked Example: A Smaller Response With Lower Concentration
On treatment day 1, concentration is 8 mg/L and response is 24 effect units. On day 8, concentration is 5 mg/L and response is 15 effect units. The observed response is lower on day 8, but concentration is also lower. Calculate the response-to-concentration ratios:
The ratio is the same on both days. Under the stated local proportionality assumption, the lower response is consistent with the lower concentration and does not provide evidence of a changed response at comparable exposure. This ratio is not a general correction for concentration: if the concentration-effect relationship is nonlinear, comparing ratios can mislead. The appropriate conclusion is limited to the available record: because concentrations are unmatched, this comparison cannot distinguish a change in exposure from a change in response at a given concentration.
Assumptions, Diagnostics, and Alternatives
These classifications are strongest when the response is measured reliably, the baseline is stable or appropriately adjusted, and the observations being compared are similar in timing and relevant conditions. Concentration measurements should also be credible and sufficiently close in time to the response measurements for the intended comparison. If concentrations vary quickly, sparse sampling may miss meaningful changes; if the response is delayed, a same-time concentration comparison may not represent the concentration driving the effect.
Useful diagnostic questions include:
- Does the response decrease within one episode, across treatment days, or on both time scales?
- Is concentration maintained or comparable at the observations that show a response difference?
- Were response measurements taken at comparable times relative to dosing?
- Has the baseline, assay, dose schedule, or clinical state changed?
- Could a delayed response explain different responses at the same measured concentration?
A concentration-effect plot can reveal whether matched concentrations are available and whether the response path differs across time. Serial response-time plots are more direct for seeing when attenuation occurs. A comparison of repeated-dose summaries is useful for a longer-term pattern but can conceal within-episode changes if each dose is reduced to one value. These displays complement one another; none, by itself, proves a biological cause.
| Approach | Best suited to | Main limitation |
|---|---|---|
| Serial response and concentration record within an episode | Assessing rapid within-episode attenuation | Delay or baseline change can mimic response loss |
| Matched-time comparisons across doses or days | Assessing gradual response change with repeated exposure | Unmatched concentration or changing conditions can confound the comparison |
| Concentration-effect plot across time | Checking for different responses at comparable measured concentrations | A loop may arise from delay and is not specific to tolerance |
The main limitation is that a response pattern is not a mechanistic diagnosis. A smaller effect after repeated dosing may reflect altered exposure, altered pharmacodynamic response, delayed response, baseline drift, or other changes. The pattern can motivate a more targeted analysis, but claims about the source of the change require evidence beyond the descriptive distinction made here.
Common Mistake
In practice, the distinction is most useful when it guides what to measure next. Dense within-episode observations help characterize rapid attenuation; repeated, comparably timed observations across treatment days help characterize gradual change. Concentration records strengthen both comparisons, while careful baseline and measurement records help prevent an apparent response loss from being attributed to the wrong time scale.
Check Your Understanding
Answer each question using the response time scale and the concentration information provided.
- During one episode, response falls from 50 to 35 effect units while measured concentration remains 6 mg/L. What is the percentage attenuation, and what pattern does this support?
- Across two treatment days, response falls from 28 to 21 effect units at the same concentration and postdose time. Calculate the percentage attenuation and identify the time-scale description supported by the record.
- Across treatment days, both concentration and response are lower on the later day. Can the response difference alone establish chronic tolerance? Explain.
- At the same concentration, response differs on the rising and falling parts of a concentration profile. Why is that not sufficient to establish acute tachyphylaxis?
Solutions. 1. Attenuation is \(100(50-35)/50=30\%\). The within-episode decline at maintained concentration is consistent with acute tachyphylaxis, but does not establish its cause. 2. Attenuation is \(100(28-21)/28=25\%\). With comparable concentration and timing, the across-day reduction is consistent with chronic tolerance. 3. No. Lower concentration may account for some or all of the lower response, so the record does not establish a response reduction at comparable exposure. 4. Delay between concentration and response can produce different responses at the same measured concentration. The time pattern and other observations are needed before describing rapid response loss.